GlassScriptPhysician profile
Angela Li
NPI 1861130452
$1,458.31
in general payments reported to CMS, 2019-2025
11 companies · $200 in 2025
The $200 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $125 · 2023: $410 · 2024: $724 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,333.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,333.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $378.97 | 2023-2025 | Repatha |
| Shockwave Medical, INC | $198.43 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Circulation INC | $190.90 | 2024 | Downstream Cartridge, Catheter, Therox Ds2 Console |
| Medtronic, INC. | $142.12 | 2024 | Symplicity G3 |
| Seagen INC. | $124.98 | 2022 | |
| Sanofi-Aventis U.S. LLC | $124.36 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $86.54 | 2023-2025 | Eliquis, Camzyos |
| Astrazeneca Pharmaceuticals LP | $75.49 | 2023-2025 | Lokelma, Farxiga |
| Esperion Therapeutics, INC. | $57.18 | 2025 | Nexletol |
| Janssen Pharmaceuticals, INC | $54.57 | 2024 | Xarelto |
| Edwards Lifesciences Corporation | $24.77 | 2025 | Sapien 3 Ultra Resilia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.